Type 1 diabetes is perhaps the only disease in which a person must make constant dosing decisions with a drug that, if improperly administered, can kill them. To ease the burden of living with T1D, we support efforts that focus on the following priorities:
Improve Outcomes for People with T1D
Most people with T1D are not achieving the American Diabetes Association’s recommended glucose targets, putting them at far greater risk of further health complications. We support promising projects to automate dosing decisions and develop novel treatments, such as glucose-responsive insulin and glucagon. We hope that with the best possible tools, more people can improve their health by achieving glucose targets.
Care Models, Tools, and Measures
To combat the shortage of endocrinologists, we support innovative models of healthcare delivery that connect people to high-quality diabetes care. We also invest in decision-support tools that can help clinicians distill overwhelming data and optimize dosing regimens. And we seek to improve the measure of well-being of people with T1D, so clinicians can interpret not just HbA1c levels, but other factors like quality of life and patient-reported outcomes.
Access to Care
All people afflicted with T1D should have access to quality care. With partners like JDRF and T1D Exchange, we collect patients’ and physicians’ perspectives so we can better understand how to expand access to and adoption of life-saving technologies. On a global level, where a regular supply of insulin is only available to half of those who need it, we examine the worldwide insulin market and try to identify the roadblocks to insulin availability.
Community Education and Support
T1D is a complex disease with an enormous burden for anyone, especially for a child. We support camperships for underserved children to attend T1D camps that offer the opportunity to interact with other young people and learn about living with the disease. We are also committed to increasing education and awareness for healthcare professionals to limit misdiagnosis and complications for people with T1D.